Prometheus Biosciences, Inc.
Prometheus Biosciences, Inc. (RXDX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · RXDX · as of Jun 9, 2026
Key Statistics
Explore Prometheus Biosciences, Inc. Data
rxdx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 11 · Buy rate: 36.4%
The RXDX analyst consensus is Hold, based on ratings from 11 Wall Street analysts over the past 3 months. The average 12-month price target is $138.57, representing -30.69% downside from the current price of $199.92.
Competitors & Peers
rxdx competitorsRXDX
BPMC
CERE
IMGN
ISEE
KRTXStock Performance
Full HistoryAbout Prometheus Biosciences, Inc.
Prometheus Biosciences, Inc. is a biopharmaceutical company primarily focused on discovering, developing, and commercializing innovative therapeutics and complementary diagnostic products, mainly targ…
what is prometheus biosciences, inc. · rxdx stock overview · prometheus biosciences, inc. company profile · who is prometheus biosciences, inc. ceo · rxdx NASDAQ · prometheus biosciences, inc. headquarters · prometheus biosciences, inc. business segments
About Stock Overview & Key Data
Prometheus Biosciences, Inc. (RXDX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Mar 12, 2021. As of the latest trading session, RXDX stock price is $199.92, with a market capitalization of $9.6B. The stock has returned +576.55% over the past 12 months and +87.54% year-to-date.
According to 11 Wall Street analysts, the consensus rating for Prometheus Biosciences, Inc. stock is Hold, with an average 12-month price target of $138.57. In fiscal year 2022, Prometheus Biosciences, Inc. reported revenue of $6.8M and net income of -$141.8M. For detailed data — including Prometheus Biosciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Prometheus Biosciences, Inc. (RXDX) stock price is $199.92. The stock is traded on NASDAQ under the ticker symbol RXDX. The 52-week range is $23.27 – $199.96.